Disease | hemolytic anemia |
Comorbidity | C0017920|glucose-6-phosphate dehydrogenase deficiency |
Sentences | 8 |
PubMedID- 26303162 | Background: primaquine is used to prevent plasmodium vivax relapse; however, it is not implemented in many malaria-endemic countries, including cambodia, for fear of precipitating primaquine-induced acute haemolytic anaemia in patients with glucose-6-phosphate dehydrogenase deficiency (g6pdd). |
PubMedID- 25756470 | Metformin-induced hemolytic anemia in a patient with glucose-6-phosphate dehydrogenase deficiency. |
PubMedID- 21502082 | However, they can cause hemolytic anemia in people with glucose-6-phosphate dehydrogenase deficiency [29]. |
PubMedID- 24434750 | Sexual stage p. falciparum gametocytes have a lifespan of over 3 weeks and are not cleared effectively by current antimalarial agents, except primaquine (pq)34, which is not widely used because it causes hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency5. |
PubMedID- 23970095 | Acute hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency complicated by ginkgo biloba. |
PubMedID- 24049258 | These include chills, fever, leukopenia, granulocytopenia, hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency, cholestatic jaundice. |
PubMedID- 23530079 | Anti-malarial 8-aminoquinolines drugs cause acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase deficiency (g6pdd). |
PubMedID- 24742291 | Nevertheless, primaquine may cause haemolytic anaemia in individuals with glucose-6-phosphate dehydrogenase deficiency (g6pdd), a major bottleneck for its large-scale use[6,7]. |
Page: 1